Aetion
Rohan Shah is a Senior Analyst at Aetion, a healthcare analytics company backed by Warburg Pincus and NEA, since June 2021. Prior to this role, Rohan served as a Research Associate at Stony Brook Medicine from March 2018 to August 2021, where research focused on fatty acid binding proteins and transient receptor potential vanilloid channels in lipid metabolism, development of a preclinical model for total knee arthroplasty in advanced osteoarthritis, and potential FABP inhibitors for pain and inflammatory disorders. Rohan holds a B.S. in Biochemistry from Stony Brook University and an Advanced Regents Diploma from St. Francis Preparatory School.
This person is not in the org chart
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.